ABIONYX Pharma vs CureVac
ABIONYX Pharma vs CureVac, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: ABIONYX Pharma is on 44/100 and CureVac on 40/100.
Where each one leads
ABIONYX Pharma
- our overall score: 44/100 against 40/100
- agent readiness: 43/100 against 38/100
CureVac
- domain rating: 66/100 against 25/100
- funding raised: $2.1B against $225M
At a glance
| Measure | ABIONYX Pharma | CureVac |
|---|---|---|
| What it is | Biopharmaceutical company developing innovative therapies for sepsis and intensive care. | Biopharmaceutical company developing mRNA-based vaccines and therapeutics for infectious diseases and cancer. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Biotech | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2015 | 2000 |
| Headquarters | Toulouse, France | Tübingen, Germany |
| Status | Active | Active |
Size, funding and growth
| Measure | ABIONYX Pharma | CureVac |
|---|---|---|
| Total funding | $225M | $2.1B |
| Latest round | Capital Increase | IPO |
| Valuation | $1.1B | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | ABIONYX Pharma | CureVac |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 44/100 | 40/100 |
| Traction | 40/100 | 40/100 |
| Team | 20/100 | Not published |
| Search visibility | 5/100 | 3/100 |
| Quality | 58/100 | 55/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (43/100) | F (38/100) |
| Domain ratingLink authority, 0-100 | 25/100 | 66/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | ABIONYX Pharma | CureVac |
|---|---|---|
| Hosting | Self Managed | Hetzner |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4 | Not detected |
ABIONYX Pharma vs CureVac: common questions
Which is better, ABIONYX Pharma or CureVac?
On our 0-100 score ABIONYX Pharma rates higher (44/100 against 40/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do ABIONYX Pharma and CureVac compare on the numbers?
ABIONYX Pharma leads on our overall score (44/100 against 40/100), agent readiness (43/100 against 38/100). CureVac leads on domain rating (66/100 against 25/100), funding raised ($2.1B against $225M).
Read the full ABIONYX Pharma review and pricing or the CureVac review and pricing. You can also browse other ABIONYX Pharma alternatives we track.